Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study | Zendy

AI Assistant Blog Pricing

Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.